Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2025-12-25 @ 12:33 AM
NCT ID:
NCT07035067
Eligibility Criteria:
Patient Inclusion Criteria
1. ≥18 years old
2. Patients with PROC who received \>1 prior line of therapy identified through a screening survey. PROC will be defined as recurrence less than 6 months after last platinum chemotherapy (i.e. carboplatin or cisplatin)
3. Ability to read and understand French or English
4. Signature of ICF
Patients Exclusion Criteria
1. Patients with PSOC, defined as those who:
1. Have not progressed within less than 6 months after completion of platinum-based chemotherapy or;
2. Are still on platinum chemotherapy or;
3. Receive maintenance therapy.
2. Patients with platinum-refractory ovarian cancer, defined as not responding or disease progressing during therapy or within three months after the last dose
Caregivers Inclusion Criteria:
1. ≥18 years old
2. Current caregiver of a patient with PROC (see definition to be used above) who received \>1 prior line of therapy identified through a screening survey.
3. Ability to read and understand French or English
4. Signature of ICF.
Caregivers Exclusion Criteria:
1. Caregivers of patients with PSOC (see definition above)
2. Caregivers of PROC patients who have passed away
3. Caregivers of platinum-refractory patients (see definition above)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07035067
Study Brief:
Protocol Section:
NCT07035067